Peer Review History
| Original SubmissionMarch 7, 2023 |
|---|
|
PONE-D-23-06552Self-care practices and associated factors among heart failure patients in Ethiopia: A systematic review and Meta-AnalysisPLOS ONE Dear Dr. Bekele, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Reviewer #1: Independent Review Report Evaluation The evaluation is for the review article titled “Self-care Practices and associated factors among heart failure patients in Ethiopia: A systematic review and Meta-Analysis” With the present study, the following areas are observed, commented and recommended. 1. Throughout the main text, it was sequential and well organized. 2. It requires grammatical corrections throughout the document. 3. This manuscript has a sum up of novelty. Comments to the author/s Abstract: 1. Try to avoid abbreviation of words in the abstract part 2. “We have used three databases such as Pub Med, Science Direct and Google Scholar. Why do you exclude other important databases that you might get potential primary studies from? 3. Heterogeneity was evaluated using the I2 tests and the Cochrane Q test statistic. What is the advantage of performing the Q test in addition to the I2 test to assess heterogeneity? 4. To examine publication bias, a funnel plot, Egger's weighted regression, and Begg's test were utilized. What is the importance of using different tests? 5. “The extent of self-care behaviour adherence is shown to be low among heart failure patients”. What is the standard reference to say “low or high”? Method 6. Please use the uniform reference citation system 7. Please try to strictly adhere to all the PRISMA 2020 guidelines to write up your paper, especially the method section. 8. Does this review registered on PROSPERO? 9. What is your last search date included in the method part? 10. What you have done if a study has low quality or higher risk? 11. “Finfinnee" is not a legal name, not yet known 12. What you have done if there is heterogeneity and publication bias between the primary studies? 13. How to perform the pooled effect of odds ratio to identify the factors associated with good selfie care? Please show on your paper as it is critical. Result 14. Table 1 column 6 gender (male). What is this??? 15. Why you have performed sub-group analysis and sensitivity test? Reviewer #2: Dear authors, thank you for your contribution. In general the issue you raised is very good. However, I have some comments and questions which described below. 1. Language edition service is required throughout the document 2. Please rephrase this sentence found in your abstract’ ‘The patient's understanding must therefore be improved by effective health education if self-care behaviour is to be improved.’’ 3. The databases scrutinized to search studies are too small. Why only three databases? I think some papers are missed. Therefore please search on at least familiar databases like HINARI, Scopus, and AJOL 4. The MESH terms are little, why? 5. Why you preferred CoCoPop? 6. With this visible heterogeneity among studies, it is difficult to accept. Therefore, I need further evidence /explanation for this because the authors even mentioned the presence the presence of heterogeneity between studies conducted in Oromia. Why? 7. In your discussion part you mentioned this’ ’The prevalence of adherence is comparable with the study conducted in Brazil (35.17%)(9) and lower than the study of Netherland(41%)(6) and Taiwan(53.37%)(26) and higher than the study of Korea(31.98%)(14). This discrepancy could be due to the difference in the study method.’’ What type of difference in study method? 8. On your limitation please rephrase this sentence’ ‘The small sample due to a limited number of included studies with a small sample size for all included studies was a limitation of this study. ‘’ 9. The number of studies included in your study is 11 but in the funnel plot it is more than 20 (each dot on the figure represent one study), Why this variation Thank you ============================== Please submit your revised manuscript by Jun 11 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mohammed Feyisso Shaka, MPH Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed: - https://doi.org/10.1186/s12889-019-8133-y - https://doi.org/10.1016/j.hrtlng.2008.11.002 In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed. 3. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free. Upon resubmission, please provide the following: ● The name of the colleague or the details of the professional service that edited your manuscript ● A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file) ● A clean copy of the edited manuscript (uploaded as the new *manuscript* file) 4. Thank you for stating the following financial disclosure: "NA" At this time, please address the following queries: a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” c) If any authors received a salary from any of your funders, please state which authors and which funders. d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. Thank you for stating the following in your Competing Interests section: "No competing interest" Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 6. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. "Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. Additional Editor Comments:
[Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Independent Review Report Evaluation The evaluation is for the review article titled “Self-care Practices and associated factors among heart failure patients in Ethiopia: A systematic review and Meta-Analysis” With the present study, the following areas are observed, commented and recommended. 1. Throughout the main text, it was sequential and well organized. 2. It requires grammatical corrections throughout the document. 3. This manuscript has a sum up of novelty. Comments to the author/s Abstract: 1. Try to avoid abbreviation of words in the abstract part 2. “We have used three databases such as Pub Med, Science Direct and Google Scholar. Why do you exclude other important databases that you might get potential primary studies from? 3. Heterogeneity was evaluated using the I2 tests and the Cochrane Q test statistic. What is the advantage of performing the Q test in addition to the I2 test to assess heterogeneity? 4. To examine publication bias, a funnel plot, Egger's weighted regression, and Begg's test were utilized. What is the importance of using different tests? 5. “The extent of self-care behaviour adherence is shown to be low among heart failure patients”. What is the standard reference to say “low or high”? Method 6. Please use the uniform reference citation system 7. Please try to strictly adhere to all the PRISMA 2020 guidelines to write up your paper, especially the method section. 8. Does this review registered on PROSPERO? 9. What is your last search date included in the method part? 10. What you have done if a study has low quality or higher risk? 11. “Finfinnee" is not a legal name, not yet known 12. What you have done if there is heterogeneity and publication bias between the primary studies? 13. How to perform the pooled effect of odds ratio to identify the factors associated with good selfie care? Please show on your paper as it is critical. Result 14. Table 1 column 6 gender (male). What is this??? 15. Why you have performed sub-group analysis and sensitivity test? Reviewer #2: Dear authors, thank you for your contribution. In general the issue you raised is very good. However, I have some comments and questions which described below. 1. Language edition service is required throughout the document 2. Please rephrase this sentence found in your abstract’ ‘The patient's understanding must therefore be improved by effective health education if self-care behaviour is to be improved.’’ 3. The databases scrutinized to search studies are too small. Why only three databases? I think some papers are missed. Therefore please search on at least familiar databases like HINARI, Scopus, and AJOL 4. The MESH terms are little, why? 5. Why you preferred CoCoPop? 6. With this visible heterogeneity among studies, it is difficult to accept. Therefore, I need further evidence /explanation for this because the authors even mentioned the presence the presence of heterogeneity between studies conducted in Oromia. Why? 7. In your discussion part you mentioned this’ ’The prevalence of adherence is comparable with the study conducted in Brazil (35.17%)(9) and lower than the study of Netherland(41%)(6) and Taiwan(53.37%)(26) and higher than the study of Korea(31.98%)(14). This discrepancy could be due to the difference in the study method.’’ What type of difference in study method? 8. On your limitation please rephrase this sentence’ ‘The small sample due to a limited number of included studies with a small sample size for all included studies was a limitation of this study. ‘’ 9. The number of studies included in your study is 11 but in the funnel plot it is more than 20 (each dot on the figure represent one study), Why this variation Thank you ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Mulugeta W/Selassie (Assistant Professor) Reviewer #2: Yes: Bekahegn Girma Negie ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Adherence to self-care practices and associated factors among heart failure patients in Ethiopia: A systematic review and Meta-Analysis PONE-D-23-06552R1 Dear Dr. Bekele, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mohammed Feyisso Shaka, MPH Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-23-06552R1 Adherence to self-care practices and associated factors among heart failure patients in Ethiopia: A systematic review and meta-analysis Dear Dr. Bekele: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Mr. Mohammed Feyisso Shaka Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .